FDA: BLUEBERRY SPARKS FIRE-BREATHING VAPORS
May 14, 2026
"Unable to contain himself, the president reportedly declared that Commissioner Makary was only one blunder away from leaving."
We were worried about the FDA with arrivals (Vinay Prasad), departures (Richard Padzur, Vinay Prasad), reversals and returns (Vinay Prasad), then again resignations (Vinay Prasad), strange decisions and ever more indecision. But today the rag is burning at the highest level of the U.S. regulatory agency: Marty Makary, FDA commissioner and on the verge of being fired, ultimately resigned on May 12 under direct pressure from the White House. Was it the second rejection, for somewhat obscure reasons, of Replimmune's anti-melanoma immunotherapy that displeased President Trump? Not at all! It was a "mundane" flavored-vaping affair...
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.
Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit.
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt.
Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum.
RELATED ARTICLES
GenoSafe Secures the Essential CLIA Certification
The French CRO specialized, among other things, in analyses for gene therapies can now analyze clinical samples coming from across the Atlantic.GenoSa
Sub-Q Bionics, Adcytherix
WORLD(United States; Israel/medtech/lymphedema) - Sub-Q Bionics has raised $1.5M in pre-seed funding from the Mayo Clinic, Yeda (Weizmann), priva
France Biotech Trophies, VolitionRx, Ambrosia Biosciences, Eli Lilly, Centessa Pharmaceuticals, ImmunityBio
FRANCE HEADLINE (Paris/Association/HealthTech) - France Biotech unveils the 2026 rankings of the "Trophées de la HealthTech". The jury,